7 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
Note: Systemic antifungals ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
Overview of antifungal ... efficacious and tolerable ... #valleyfever #management ... #treatment #antifungals ... comparison #table #pharmacology
Diagnosis and Management of Achalasia - ACG Guidelines

Who to suspect?
 • Patients presenting with progressive dysphagia
Diagnosis and Management ... of Achalasia - ... Botulinum toxin • Pharmacologic ... #Diagnosis #Management ... ACG #Guidelines #gastroenterology
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
Infection General Management ... Patients with Sulfa Intolerance ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
Antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis
Fluconazole
 - Benefits: Low cost/tolerable
Antifungal agents ... Benefits: Low cost/tolerable ... chest/back pain #Antifungal ... Coccidioidomycosis #pharmacology ... #management #treatment
Systemic Therapy for Hepatocellular Carcinoma - AGA Clinical Practice Guideline

First Line Treatment for HCC with Preserved
Progression or Intolerance ... Systemic #Treatment #Management ... #Hepatology #Gastroenterology ... #oncology #Pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
interactions or intolerance ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology